Hesham A. El‐Mahdy

New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studies

Hazem Elkady, Alaa Elwan, Hesham A. El‐Mahdy et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 118 citations · Full text

Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein

Hesham A. El‐Mahdy, Ahmed A. El-Husseiny, Yasser I. Kandil et al. · Life Sciences · 2020 · 81 citations

Tumor Biology, Pancreatic Cancer, Medicine +6

New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story

Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady et al. · Journal of Molecular Structure · 2023 · 42 citations

Cadd Story, Oncology, Breast Oncology +11

Comparison of Bovine- and Porcine-Derived Decellularized Biomaterials: Promising Platforms for Tissue Engineering Applications

Hussein M. El‐Husseiny, Eman A. Mady, Masahiro Kaneda et al. · Pharmaceutics · 2023 · 21 citations · Full text

Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-<i>d</i>]pyrimidines targeting VEGFR-2

Souad A. El‐Metwally, Hazem Elkady, Mohamed Hagras et al. · RSC Advances · 2023 · 16 citations · Full text